Although it is clear that fetal lung development is accelerated by a number of hormones, it has not been established that circulating hormones are responsible for inducing expression of the genes responsible for surfactant synthesis (I). In the rat, mouse, and sheep, but not the rabbit, free plasma corticosteroid levels have been reported to rise at about the same time that the surge in surfactant production occurs (2). Studies with organ cultures from a variety of species have indicated that the biochemical and anatomical maturation of the fetal lung begins and continues in culture in the absence of added hormones (I, 3-lo), whereas studies with isolated cells have suggested that corticosteroids are necessary for biochemical development in culture (11, 12 fetal rat lung will develop in culture in the presence of medium containing 1 % FCS or no serum at all (I). In the case of the later gestation (18-20 d) explants, it is possible that as the tissue had already been exposed to hormones in vivo, maturation was stimulated before the lung tissue was cultured. The earlier gestation (14-15 d) explants were cultured in the presence of 1 % FCS that contained trace amounts of hormones, including 0.5 nM cortisol. It is possible that these small amounts of hormones were adequate to initiate lung maturation, that the lung tissue already contained active hormones, or that it converted inactive hormones to their active forms. In contrast to the findings in explants, studies with monolayer cultures of mixed fetal lung cells have indicated that corticosteroids are necessary for promoting lung differentiation in culture and that in the absence of these hormones lung differentiation is arrested (I I, 12).
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In an attempt to resolve the issue of whether glucocorticoids are responsible for initiating surfactant synthesis, we have cultured explants of 15-to 17-d fetal rat lung medium in which the serum was treated with charcoal to remove low-mol-wt substances or to which various glucocorticoid antagonists, including the potent steroid receptor antagonist RU 486 [I lp-(4-dimethyl aminophenyl) 17P-hydroxy, 17a-(prop-l ynyl) estra 4,9-dien-3-one], were added. RU 486 is a synthetic steroid with a high binding affinity for progesterone and glucocorticoid receptors (13) . It has previously been shown to have no agonist activity, but to have strong antiglucocorticoid effects in vivo and in vitro (13, 14) . We examined the effects of glucocorticoid receptor blockade on phospholipid synthesis and the appearance of mRNA for the 35-kD SP-A.
MATERIALS AND METHODS
Tissue culture. All experiments were performed with explants of 15-or 17-d fetal rat lung, cultured for up to 7 d. The culture technique has been described in detail previously (1, 15) . The lungs were removed under sterile conditions and dissected free of connective tissue and large airways. The lungs were then separated into individual lobes and the lobes cut into small pieces (see Fig. 2B under "Results"). The explants were placed on either side of a 60-mm-diameter tissue culture dish that contained 2 ml of Waymouth's MB 75211 medium with 100 U of penicillin, 100 mg of streptomycin, and 3.0 pg fungizone/ml as well as various additions as are described below. Scratches were made on the culture dishes to promote adherence of the explants. The culture medium was changed every other day. The dishes were rocked from side to side on a rocking platform at about 3 cycles/ min so that at any one time half the explants were exposed to the culture medium and the other half to the humidified atmosphere of 95% air, 5% C 0 2 in the case of 15-d lung explants or 50% 02, 45% N2 and 5% COz in the case of the 17-d explants.
(Our previous studies have indicated that as fetal rat lung matures 240 GROSS the requirement for oxygen by explant cultures increases; the concentrations used here were optimal for gestational age.)
Addilions to cullure medium. For the studies of morphologic development and phospholipid synthesis, explants of 15-d lung were used. Control cultures were grown in Waymouths's medium with 1 % FCS. Aliquots of this serum were also charcoal treated by the method of Sato (1 6) , and a group of explants was cultured in medium with 1 % charcoal-stripped FCS. Other cultures were incubated in control medium with 0.1-to 10-pM clotrimazole, 0.1 -to 10-pM cortexolone (1 1-desoxy-17 hydroxycorticosterone), 10-to 1000-nM 1 1-ketoprogesterone, 20-to 200-nM RU 486, or 50-nM dexamethasone. For the studies of mRNA accumulation, explants of 17-d lung were cultured in Waymouth's medium with 1% charcoal-stripped serum in the presence or absence of 100-nM RU 486.
Lipid synthesis. After varying periods in culture, the medium was aspirated and replaced with fresh medium containing 12 pCi/mol [methyl-3H]choline chloride, 2.23 Ci/mol, or 26 pCi/ ml [3H]Na acetate, 6.4 Ci/mol. Incubation was continued for an additional 4 h. The explants were then washed with ice-cold 0.9% NaCI, lipids were extracted, phospholipids were isolated by thin-layer chromatography, and the radioactivity in the various phospholipid fractions was determined by methods described previously (1 5) . Protein content was measured by the method of Lowry et al. (17) using BSA as a standard.
Glucocorticoid binding. Binding of dexamethasone was assayed using intact cell techniques as described previously ( 1 8). After 24 h of preincubation in various concentrations of RU 486 or clotrimazole, [3H]dexamethasone, 35 nmol, was added to the explants, and incubation was continued for 3 h at 37°C. An aliquot of the incubation medium was counted to determine the concentration of free dexamethasone. At the end of the incubation, the tissue was washed with ice-cold saline and homogenized in cold buffer. A nuclear and cytoplasmic fraction were prepared by centrifugation as described previously (3) . To remove free dexamethasone, the cytoplasmic fraction was applied to a Sephadex G 25 column, and the void vol collected and retained. The nuclear fraction was washed twice, and radioactivity in both fractions was determined by liquid scintillation counting. Nonspecific binding, determined in the presence of a 500-fold excess of dexamethasone, was subtracted from total binding to give specific binding.
RNA extraction and Northern blotting. Explants were washed and harvested in cold sterile 0.9% NaCl and hand homogenized in 4-M guanidinium thiocyanate, 25-mM sodium citrate, pH 7.0, 0.5% sodium N-lauroyl sarcosinate and 0.1-M P-mercaptoethanol (19, 20) . DNA was sheared by aspiration several times through a 22-gauge needle.
A total of 2.5 ml of homogenate was layered onto an equal vol of 5.7-M cesium chloride, 0.1-M EDTA, pH 7.0, and centrifuged at 100,000 x g for 20 h. The pellet was rinsed with 70% ethanol, suspended in 0.1-M Tris EDTA, pH 7.0, and then precipitated with 0.1-M sodium acetate and 100% ethanol and centrifuged for 15 min at 15,000 x g. This procedure was repeated three times. The pellet was then suspended in water. The amount of RNA was determined by the OD at 260 nm. Explants from the same experiment were processed simultaneously.
Next, 20 or 40 pg of total RNA in buffer were loaded into each well of a 1 % agarose 6.3% formaldehyde gel. After electrophoresis, the gels were stained with ethidium bromide, and the RNA bands were visualized under UV light. RNA was then transferred to Genescreen filters according to the recommendations of the vendor (New England Nuclear, Boston, MA). The Genescreen filter was washed, dried, and baked at 80°C for 4 h.
Rat lung SP-A cDNA probe. The Genescreen filters were hybridized with a rat lung SP-A cDNA probe which will be described in more detail elsewhere (J. Floros, D.S. Phelps, H.P. Harding, S. Church, J. Ware, in preparation). To isolate the cDNA clone, a rat lung cDNA library was screened with a human SP-A cDNA probe (21) . The positive clones were further characterized by hybrid selection. The selected mRNA was translated in an in vitro translation system, and the translation products from the selected RNA were identical to the rat SP-A primary translation products when rat lung RNA was used (22) . In addition, the translation products from the selected RNA are immunoprecipitable with an antiserum to human SP-A (20, 22, 23) and antiserum to rat SP-A. The positive rat cDNA clone recognizes the two different-sized SP-A mRNA described by Sano et a1 (24) .
Hybridization assay. The SP-A cDNA was labeled with [a-32P]dCTP (3000 Ci/mmol) using a nick translation kit obtained from Amersham Corp. (Arlington Heights, IL). The probe was labeled to a sp act of 10'-lo8 cpm/pg. The Genescreen filters were prehybridized overnight at 42°C and then hybridized to the [33P]dCTP-labeled SP-A cDNA probe (2-3 x lo5 cpm/ml of hybridization solution) for 2-3 d at 42°C. The conditions and buffers used for hybridization and washing of the filters were as described by the vendor (Biotechnology Systems, New England Nuclear Research Products. Feb. 1987). The filters were then exposed to XAR Kodak film (Eastman Kodak Co., Rochester, NY) with an intensifying screen at -70°C for a few d. The density of the specific RNA bands on the autoradiograms was quantified by a laser densitometer (Biomed Instruments, Fullerton, CA).
Materials. (13, 14) and clotrimazole (25) have been shown to inhibit glucocorticoid binding in a variety of organs and cell lines, including rat liver and thymus and hepatoma cells. To determine whether these compounds inhibit glucocorticoid binding in fetal rat lung, explants were cultured in the presence of Concentration of glucocortico~d antagonist in medium ( n M ) Fig. 1 24 1 0.1-to 10-pM clotrimazole or loo-, 500-, or 1000-nM RU 486 for 24 h. After this preincubation, specific dexamethasone binding was determined under conditions that had previously been shown to be optimal. Clotrimazole had no effect on glucocorticoid binding. As is shown in Figure 1 , RU 486 markedly antagonized both cytoplasmic and nuclear dexamethasone binding. At a concentration of 100-nM RU 486 (and 35-nM [3H]dexamethasone), specific glucocorticoid binding was reduced to less than 10% of the control value, and there was a further reduction with increasing concentrations of the antagonist. To determine whether RU 486 also had an agonist effect, explants of 18-d fetal rat lung were cultured in the presence of 20 -to 200-nM RU 486 for 48 h under conditions which had previously proven optimal for demonstrating dexamethasone stimulation in this system (26) . There was no significant enhancement of choline incorporation into phosphatidylcholine with any of these concentrations of RU 486. In addition, when 17-d lung explants were incubated for 72 h with 50-nM dexamethasone, the dexamethasone-induced 75% stimulation of choline incorporation was reduced to less than half if 100-nM RU 486 was also added to the incubation medium. (Data not shown.)
The effects of incubation with control medium (1 % serum) or RU 486 on the overall morphologic development of the lung explants are shown in Figures 2, 3 , and 4. As is shown in Figure  2A , the lungs of the 15-d fetal rat consist of tubular epithelial tissue which has just begun to bud into the surrounding mesenchyme. An example of the pieces of lung which were used in the cultures is shown in Figure 2 B. After 3 d in culture in control medium (1% serum), there was considerable budding of the respiratory tract (Fig. 3) . By 5 d, the budding had progressed further in the control cultures (Fig. 4 A) and the mesenchymal tissue had become completely incorporated into the structure of the lung. Culturing the explants in medium with RU 486 (Fig. 4  B) did not produce any obvious inhibition of this process. This observation was consistent in six experiments.
The rate of choline incorporation into disaturated phosphatidylcholine increased considerably over 7 d in culture. As Table  1 shows, there was a more than 75% increase in choline incorporation into disaturated phosphatidylcholine from d 3 to 7 when explants of 15-d lung were cultured in the presence of 1 % FCS, whether or not the serum had been charcoal treated. Addition of RU 486 to the culture medium did not inhibit choline incorporation into disaturated phosphatidylcholine in the cultures. As is shown in Table 2 , the increase in incorporation for 3-7 d in culture was at least as great in those cultures that were exposed to RU 486 as in control cultures. The percentage of phosphatidycholine that was disaturated was examined after incubation with [3H]acetate. This ratio was 38.9% after 2 d in culture and increased to 43.3% in control cultures and 45.1 % in RU 486-treated cultures after 7 d. After 2 d, 1.9% of the phospholipid radioactivity was found in the phosphatidylglycerol fraction. After 7 d, the values were 1.8% in the controls and 3.0% in the RU 486-treated explants. None of these changes were statistically significant (N = 3).
Exposure of the explants for 7 d to clotrimazole, a putative glucocorticoid receptor antagonist (25) , at concentrations of 0.1, 1.0 and 10.0 FM; cortexolone, a glucocorticoid antagonist (27) , at concentrations of 0. I, 1 .O, and 10.0 FM; or I 1 -ketoprogesterone, an inhibitor of the conversion of dehydrocorticosterone to the more active form corticosterone (28), at concentrations of 10, 100, and 1000 nM did not result in inhibition of choline incorporation as compared to control cultures. At the highest concentration of cortexolone, the explants did not grow well, and there was a considerable decrease in the amount of protein in these cultures.
Similar results were obtained when the influence of RU 486 on the accumulation of mRNA for SP-A was examined in explants of 17-d lung cultured for 5 d. No mRNA was detectable in Northern blots of RNA extracted from preculture 17-d lung. After 5 d in culture in medium with 1 % charcoal-stripped serum, specific mRNA was detectable and was not reduced by addition of RU 486, 100 nM, to the culture medium (Fig. 5) . The mRNA bands were quantified by means of a laser densitometer, confirming the absence of an inhibitory effect of RU 486. The integrated area under the densitometer generated curve (in arbitrary units) was 28.5 k 3.7 for the controls and 33.2 + 8.2 for the RU 486-treated cultures, n = 3.
DISCUSSION
An unresolved issue in fetal lung development is whether the genes responsible for the synthesis of the many components of surfactant are activated by circulating hormones or by intrinsic pulmonary stimuli such as growth factors, products of the extracellular matrix, or cell-cell interactions. Although it is clear that hormones such as glucocorticoids and thyroid hormone accelerate fetal lung maturation in vivo and in vitro, it has not been established that these or other hormones are responsible for initiating surfactant production. The data that have been published thus far are somewhat contradictory. Some in vivo studies have shown that surfactant synthesis increases in lambs before the rise in cortisol levels; others have not (29-3 1) . In the rat (32, 33) and mouse (34) plasma free corticosteroid levels rise at about the same time that surfactant production increases, but this is not the case in the rabbit (2) . The assumption underlying these studies has been that a rise in hormone levels preceding or coinciding with the increase in surfactant production would provide evidence for a causal relationship between the two events. A number of studies have also examined the effect of hypophysectomy or decapitation on fetal lung maturation. These studies have generally shown that under these conditions fetal lung maturation is considerably delayed, but not that it is necessarily stopped. For example, when the pituitary of fetal sheep of 99-122 d gestation was ablated, there was a resulting reduction in circulating cortisol and prolactin levels. Lung maturation in these animals was retarded so that at term the degree of maturity was comparable to that in 130-d fetuses (29, 35) . Development of the lung did, however, continue at a slow rate in the absence of pituitary hormones.
Other researchers (3-9) and we ourselves (1, 10) have previously shown that fetal human, rat, and rabbit lung continues both biochemical and morphologic maturation [including the appearance of lamellar bodies in alveolar lining cells (lo)] in organ or organotypic culture in systems in which the culture medium was kept constant and there could not have been any surge in hormone levels. Our experiments with fetal rat lung were conducted with either serum-free medium or medium containing 1 % serum in which the level of hormones was measured, found to be low, and was well below the concentration that produces half maximal stimulation for phosphatidylcholine synthesis (I). We noted that development in culture occurred in a pattern similar to that seen in vivo, although in explants of early fetal lung it was not as rapid as that in vivo or in cultures of later gestation fetal lung. This may relate to the fact that in vivo and in the cultures of late gestation lung the tissue is or has been exposed to relatively high levels of circulating hormones. [Levels of corticosterone and thyroid hormones start to increase significantly about 4 d before term in the rat (32, 36) .] It should also be noted that our early fetal rat lung explants do not demonstrate the accelerated development in organ culture that has been reported with lung tissue from other species, particularly the human (3, 7, 9) . The accelerated maturation in human lung explants raises the possibility that in vivo development may also be regulated by circulating inhibitors from whose influence these explants are released.
In contrast to the findings with the intact explants, studies with enzymatically dissociated monolayer cultures of mixed fetal rabbit (12) and rat (1 1) lung cells have found that differentiation in culture is dependent on the presence of corticosteroid in the medium. In addition, Torday (27) has reported that in explants of 19-d fetal rabbit lung, maturation in culture was inhibited by the use of charcoal-stripped serum or the addition of 10-pM cortexolone to the culture medium. Development was restored by the addition of cortisol to the medium.
To attempt to resolve the issue of whether early fetal rat lung has a requirement for glucocorticoid to begin surfactant synthesis, we have compared the development of cultures grown in medium containing 1 % FCS to that of cultures in which the FCS was charcoal stripped or to which a variety of glucocorticoid antagonists were added. We have shown previously that fetal rat lung explants respond to glucocorticoids by increasing surfactant phospholipid synthesis in a dose-dependent fashion (15, 26) . Whereas the cultures remained responsive to glucocorticoids and development could be further accelerated by addition of glucocorticoids to the culture medium, no significant delay in macroscopic morphologic maturation or disaturated phosphatidylcholine synthesis was observed in the cultures grown in charcoalstripped serum. Similarly, exposure to a wide range of concentrations of cortexolone, a glucocorticoid antagonist, and 11-ketoprogesterone, a blocker of the conversion of inactive dehydrocorticosterone to corticosterone (that has been shown to delay lung maturation in vivo) (28) , did not result in a reduction in disaturated phosphatidylcholine synthesis. Clotrimazole, a blocker of glucocorticoid binding in some systems (25) , did not antagonize dexamethasone binding in the fetal lungs, nor did it inhibit phosphatidylcholine synthesis.
The most interesting results were those obtained with RU 486. This potent glucocorticoid-binding antagonist has been shown to interact very strongly with the cytoplasmic glucocorticoid receptor in a number of tissues, including rat thymus and a hepatoma cell line (13, 14) . RU 486 inhibits a number of glucocorticoid-induced effects, including ACTH release in pituitary cells, uridine incorporation in thymocytes, and tyrosine aminotransferase induction (14) , but it has no glucocorticoid agonist activity (13) . We have shown that RU 486 is a potent glucocorticoid antagonist in fetal rat lung tissue. It almost completely abolished specific cytoplasmic and nuclear glucocorticoid binding when added to the culture medium in a 3:l ratio with dexamethasone and had no glucocorticoid agonist activity as determined by phosphatidylcholine synthesis, even in concentrations up to 200 nM. The concentration of total cortisol in undiluted FCS (Grand Island Biological Co., Grand Island, NY) was found to be 41 nM in a previous study (1) . As 1% FCS would contain approximately 0.5-nM cortisol, 20-nM RU 486 should have been more than adequate to completely negate any glucocorticoid effects due to cortisol in the medium or from residual corticosterone present in the lung tissue. [We have previously shown that corticosterone and dexamethasone compete for the same glucocorticoid receptor in fetal rat lung (15) , so it can be assumed that RU 486 inhibited corticosterone as well as dexamethasone binding. Corticosterone binds with lower affinity than dexarnethasone.] Addition of RU 486 to the culture medium in concentrations varying from 20-200 nM had no obvious effect on macroscopic morphologic development and did not inhibit the development of disaturated phosphatidylcholine synthesis or the appearance of mRNA for SP-A in the cultures. As glucocorticoid stimulation of fetal lung phosphatidylcholine synthesis requires the presence of receptor-bound steroid (37) , receptor blockade is a very specific approach to evaluating the role of glucocorticoids.
This study does not exclude the possibility that the subsequent expression of the genes involved in surfactant production is influenced by exposure to glucocorticoids or other hormones early in development. These data do, however, provide strong evidence that the induction of expression of the genes for SP-A and the enzymes regulating surfactant phospholipid synthesis are not dependent on the presence of glucocorticoids. The concentration of other hormones in culture medium with 1 % FCS was extremely low and unlikely to influence lung maturation (free T4, 0.5 pM; total T3, 15 pM) (1). The fact that enzymatically dispersed lung cell cultures appear to be dependent on glucocorticoids for their continuing development (1 1, 12) and the more intact explants do not suggests that endogenous factors such as extracellular matrix components, cell to cell interactions, or growth factors may play a major role in initiating surfactant production. It seems likely that the genes responsible for surfactant production are activated by signals contained within the lung tissue itself and that the role of circulating hormones is later acceleration and modulation of this process.
